Dauntless 1, Inc. — Form D/A
Dauntless 1, Inc. of SAN DIEGO, CA, a company, filed a Form D amendment with the SEC on 2016-04-15. The offering totals $12.0M, of which $7.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2016-04-15
- Form: D/A
- Accession: 0001644062-16-000002
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $12.0M
- Amount sold: $7.0M
- Remaining: $5.0M
- Investors: 5
- Date of first sale: 2015-05-14
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-241436
Issuer
- Name: Dauntless 1, Inc.
- CIK: 0001644062
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 12390 El Camino Real, Suite 170, SAN DIEGO, CA, 92130
- Phone: 858-922-8919
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| David Kabakoff, Ph.D. | Director | Menlo Park, CA |
| Joel Martin, Ph.D. | Director | San Diego, CA |
| Michael Powell, Ph.D. | Director | Menlo Park, CA |
| Joel Martin, Ph.D. | Executive Officer | San Diego, CA |
| Joel Martin | Director | La Jolla, CA |
| Joel Martin | Executive Officer | La Jolla, CA |
| David Kabakoff | Director | Brisbane, CA |
| Michael Powell | Director | Cambridge, MA |
Other filings by this issuer (2)
More